Skip to Main content

Researcher identifiers

Number of documents

1

Valerie Serval, PhD

 

IdRef : 112455492 
ORCID  0000-0002-5439-0695

VIAF : http://viaf.org/viaf/213207845  ISNI : 0000000359308926
Web of Science ResearcherID  ABA-2692-2020
Scopus (Mendeley)   6508097806

 

 

This article  below in the Journal of Pharmacology and Experimental Therapeutics is  not included  by HAL as of Feb 26, 2021.  Serval, V., Galli, T., Cheramy, A., Glowinski, J. & Lavielle, S. In vitro and in vivo inhibition of N-acetyl-L-aspartyl-L-glutamate catabolism by N-acylated-L-glutamate analogs. J. Pharmacol. Exp. Ther. 260, 1093–1100 (1992).

Though quoted in Nature Reviews drug discovery as of 24 november 2005

by  Zhou, J., Neale, J., Pomper, M. et al.    NAAG peptidase inhibitors and their potential for diagnosis and therapy.

 

Nat Rev Drug Discov 4, 1015–1026 (2005).   https://doi.org/10.1038/nrd1903

 

 

 

 

 

 

 

 

Journal articles1 document

  • Anna Pittaluga, Luis Barbeito, Valérie Serval, Gérard Godeheu, Françoise Artaud, et al.. Depolarization-evoked release of N-acetyl-L-aspartyl-L-glutamate from rat brain synaptosomes: Depolarization-evoked release of NAAG from rat brain synaptosomes. European Journal of Pharmacology, Elsevier, 1988, 158 (3), pp.263-266. ⟨10.1016/0014-2999(88)90076-3⟩. ⟨hal-02935045⟩